/IMUN
IMUN Stock - Immune Therapeutics, Inc.
Healthcare|BiotechnologyOTC
$0.09-7.00%
$0.01 (-7.00%) • Oct 18
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IMUN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.09 – $0.09
TARGET (TP)$0.11
STOP LOSS$0.09
RISK/REWARD1:5.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.26
52W High$1.30
52W Low$0.07
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $113,500 |
| Gross Profit | N/A | N/A | N/A | N/A | $65,827 |
| Gross Margin | N/A | N/A | N/A | N/A | 58.0% |
| Operating Income | $-1,163,000 | $-738,000 | $-887,000 | $-2,838,000 | $-4,085,000 |
| Net Income | $-5,788,000 | $3.59M | $1.11M | $-4,673,000 | $-8,175,000 |
| Net Margin | N/A | N/A | N/A | N/A | -7202.6% |
| EPS | $-0.16 | $7.41 | $2.40 | $-10.44 | $-19.03 |
Company Overview
Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IMUNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2023
EPS Surprise History
Q4 21
No data
Q2 22
No data
Q2 22
No data
Q4 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.04 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.50 | — | — |
Q2 2022 | May 3, 2022 | — | $-5.29 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.42 | — | — |
Q4 2021 | Nov 12, 2021 | — | $0.24 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.23 | — | — |
Q2 2021 | May 24, 2021 | — | $0.05 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-1.99 | — | — |
Q3 2020 | Sep 30, 2020 | — | $0.24 | — | — |
Q2 2020 | Jun 29, 2020 | — | $-1730.00 | — | — |
Q2 2020 | May 14, 2020 | — | $-2120.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-2.02 | — | — |
Q4 2019 | Nov 19, 2019 | — | $-2070.00 | — | — |
Q3 2019 | Aug 14, 2019 | — | $-1.81 | — | — |
Q2 2019 | May 20, 2019 | — | $-1.58 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-2.32 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IMUN
What is IMUN's current stock price?
Immune Therapeutics, Inc. (IMUN) is currently trading at $0.09 per share. The stock has moved -7.00% today.
What is the analyst price target for IMUN?
No analyst price targets are currently available for this stock.
What sector is Immune Therapeutics, Inc. in?
Immune Therapeutics, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is IMUN's market cap?
Immune Therapeutics, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does IMUN pay dividends?
No, Immune Therapeutics, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNOEF
Bionomics Limited
$0.01
Mkt Cap: $0.0B
CRBKF
Carebook Technologies Inc.
$0.03
Mkt Cap: $0.0B
FWPAY
Forward Pharma A/S
$300.00
Mkt Cap: $0.0B
HBCNF
HealthBeacon plc
$0.50
Mkt Cap: $0.0B
IPCIF
Intellipharmaceutics International Inc.
$0.15
Mkt Cap: $0.0B
MXDHF
MDxHealth S.A.
$0.25
Mkt Cap: $0.0B
POLXF
Polydex Pharmaceuticals Limited
$1.99
Mkt Cap: $0.0B
TBPMF
Tetra Bio-Pharma Inc.
$0.00
Mkt Cap: $0.0B
TPPRF
Top Strike Resources Corp.
$0.04
Mkt Cap: $0.0B
TRYPF
Tryp Therapeutics Inc.
$0.06
Mkt Cap: $0.0B
Explore stocks similar to IMUN for comparison